Request for Covid-19 Impact Assessment of this Report
The global Receptor Tyrosine Protein Kinase ERBB 3 market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
GlaxoSmithKline Plc
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
Major applications as follows:
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
Major Type as follows:
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Regional market size, production data and Trade:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 AstraZeneca Plc
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 AVEO Pharmaceuticals, Inc.
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Etubics Corporation
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 F. Hoffmann-La Roche Ltd.
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 GamaMabs Pharma S.A.
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 GlaxoSmithKline Plc
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 GlaxoSmithKline Plc
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 ImmunoGen, Inc.
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Kolltan Pharmaceuticals, Inc.
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Merrimack Pharmaceuticals, Inc.
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Merus B.V.
3.12 Novartis AG
3.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
3.14 Sihuan Pharmaceutical Holdings Group Ltd.
3.15 Sorrento Therapeutics, Inc.
3.16 Symphogen A/S
3.17 Takis S.r.l.
4 Major Application
4.1 Non-Small Cell Carcinoma
4.1.1 Overview
4.1.2 Non-Small Cell Carcinoma Market Size and Forecast
4.2 Solid Tumor
4.2.1 Overview
4.2.2 Solid Tumor Market Size and Forecast
4.3 Melanoma
4.3.1 Overview
4.3.2 Melanoma Market Size and Forecast
4.4 Colorectal Cancer
4.4.1 Overview
4.4.2 Colorectal Cancer Market Size and Forecast
4.5 Others
4.5.1 Overview
4.5.2 Others Market Size and Forecast
5 Market by Type
5.1 BA-0702
5.1.1 Overview
5.1.2 BA-0702 Market Size and Forecast
5.2 CDX-3379
5.2.1 Overview
5.2.2 CDX-3379 Market Size and Forecast
5.3 Elgemtumab
5.3.1 Overview
5.3.2 Elgemtumab Market Size and Forecast
5.4 ETBX-031
5.4.1 Overview
5.4.2 ETBX-031 Market Size and Forecast
5.5 Others
5.5.1 Overview
5.5.2 Others Market Size and Forecast
5.6 Others
5.6.1 Overview
5.6.2 Others Market Size and Forecast
6 Conclusion
Tab Regional Production 2012-2017 (Volume)
Tab Regional Demand and CAGR 2012-2017 (Million USD)
Tab Regional Demand and CAGR 2012-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of AVEO Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Etubics Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of GamaMabs Pharma S.A.
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of ImmunoGen, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Kolltan Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Merrimack Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Merus B.V.
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Sihuan Pharmaceutical Holdings Group Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of Sorrento Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Symphogen A/S
Tab Sales Revenue, Volume, Price, Cost and Margin of Takis S.r.l.
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...